These findings suggest that the ceRNA network may play a crucial role in chronic myeloid leukemia (CML) by modulating the expression of CAMK2B, CDC25C, SV2A, and GRM1. This evidence concerns the gene CAMK2B and chronic myelogenous leukemia, BCR-ABL1 positive.